Purpose: To present a case of partially reversible retinal toxicity related to a newer epilepsy medication, ezogabine (Potiga).
Methods: Case report with multimodal imaging.
Patient: A patient presented 9 months after starting ezogabine for a screening eye examination with new retinal pigment abnormalities in the maculas of both eyes.